Development of vaccinia virus-based vaccines against smallpox

  • Email
  • Help
Current effective version

Adopted guideline

Reference numberCPMP/1100/02
Effective from01/07/2002
KeywordsSmallpox, second generation, vaccinia virus, first generation, smallpox vaccines, bioterrorism, tissue culture, eggs
DescriptionThis document addresses the manufacture and preclinical/clinical development of smallpox vaccines. It applies to vaccines produced by means of growing vaccinia virus in tissue culture or in emryonated hens' eggs. It provides guidance on the data to be submitted in an application for marketing authorisation.

Related content

How helpful is this page?

Average rating:

 Based on 25 ratings

Add your rating:

See all ratings
5 ratings
5 ratings
5 ratings
5 ratings
5 ratings

Tell us more